COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Skip to Main Navigation
Skip to Page Content
Skip to Atlas Navigation

Stomach, Glandular Stomach, Neuroendocrine Cell - Hyperplasia

Image of hyperplasia in the glandular stomach neuroendocrine cell from a female F344/N rat in a chronic study
Stomach, Glandular stomach, Neuroendocrine cell - Hyperplasia in a female F344/N rat from a chronic study. The mucosa is expanded by a pale focus of cells.
Figure 1 of 6
Image of hyperplasia in the glandular stomach neuroendocrine cell from a female F344/N rat in a chronic study
Stomach, Glandular stomach, Neuroendocrine cell - Hyperplasia in a female F344/N rat from a chronic study (higher magnification of Figure 1). The hyperplastic cells have small cytoplasmic vacuoles and are grouped in to small clusters separated by a fine vascular stroma.
Figure 2 of 6
Image of hyperplasia in the glandular stomach neuroendocrine cell from a female F344/N rat in a chronic study
Stomach, Glandular stomach, Neuroendocrine cell - Hyperplasia in a female F344/N rat from a chronic study. The mucosal glands are separated by smaller cells with fine cytoplasmic vacuoles.
Figure 3 of 6
Image of hyperplasia (Sevier-Munger stain) in the glandular stomach neuroendocrine cell from a female F344/N rat in a chronic study
Stomach, Glandular stomach, Neuroendocrine cell - Hyperplasia in a female F344/N rat from a chronic study (Sevier-Munger stain). The cells separating the glands stain positively with a silver stain.
Figure 4 of 6
Image of hyperplasia (Chromagranin A immunohistochemistry) in the glandular stomach neuroendocrine cell from a female F344/N rat in a chronic study
Stomach, Glandular stomach, Neuroendocrine cell - Hyperplasia in a female F344/N rat from a chronic study (Chromagranin A immunohistochemistry). The cells separating the glands are immunopositive for Chromagranin A.
Figure 5 of 6
Image of hyperplasia (Sevier-Munger stain) in the glandular stomach neuroendocrine cell from a female F344/N rat in a chronic study
Stomach, Glandular stomach, Neuroendocrine cell - Hyperplasia in a female F344/N rat from a chronic study (Sevier-Munger stain). The gastric glands are separated by pale-staining cells.
Figure 6 of 6
next arrow
View all images

comment:

Hyperplasia of the neuroendocrine cells consists of increased numbers of neuroendocrine cells in the mucosa. The neuroendocrine cells are attached to the mucosa basement membrane and are wedged between the mucous, parietal, and chief cells; some neuroendocrine cells have cytoplasmic extensions that reach the mucosa lumen. Because of their attachment to the basement membrane, hyperplasia will be noted primarily in the lower half of the mucosa. Neuroendocrine cells are difficult to recognize with H&E stains but are identifiable with special argyrophilic stains (Grimelius, Sevier-Munger), immunohistochemistry, or electron microscopy. Argyrophilic stains reveal small granules in the cytoplasm. Chromagranins are proteins that represent the predominant constituent of neurosecretory granules, so antibodies to Chromagranin A are used to identify neuroendocrine cells in tissue sections. Hyperplasia of the neuroendocrine cells of the glandular stomach can be induced with histamine 2 blockers or proton pump inhibitors and was seen in the NTP chronic methyleugenol gavage study. In addition, rats and mice in the methyleugenol study had an increase in neuroendocrine tumors of the glandular stomach. Hyperplasia of the neuroendocrine cells of the glandular stomach is not seen as a background lesion.

recommendation:

Neuroendocrine hyperplasia should be diagnosed and graded whenever present. Grading should be based on the number of hyperplastic neuroendocrine cells present.

references:

Betton GR. 1998. The digestive system I: The gastrointestinal tract and exocrine pancreas. In: Target Organ Pathology (Turton J, Hooson J, eds). Taylor and Francis, London, 29-60.

Brown HR, Hardisty JF. 1990. Oral cavity, esophagus and stomach. In: Pathology of the Fischer Rat (Boorman GA, Montgomery CA, MacKenzie WF, eds). Academic Press, San Diego, CA, 9-30.
Abstract: http://www.ncbi.nlm.nih.gov/nlmcatalog/9002563

DeLellis RA, Dayal Y. 2007. The neuroendocrine system. In: Histology for Pathologists, 3rd ed (Mills SE, ed). Lippincott Williams and Wilkins, Philadelphia, PA, 1189-1210.

Johnson JD, Ryan MJ, Toft JD II, Graves SW, Hejtmancik MR, Cunningham ML, Herbert R, Abdo KM. 2000. Two-year toxicity and carcinogenicity study of methyleugenol in F344/N rats and B6C3F1 mice. J Agric Food Chem 48:3620-3632.
Abstract: http://pubs.acs.org/doi/abs/10.1021/jf000364a

National Toxicology Program. 2000. NTP TR-491. Toxicology and Carcinogenesis Studies of Methyleugenol (CAS No. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, Research Triangle Park, NC.
Abstract: http://ntp.niehs.nih.gov/go/10172

Back to top

Web page last updated on: November 17, 2014